Diseases
Oyo State Government, under the leadership of Governor, has taken a proactive approach to protect livestock and public health by vaccinating a significant number of cattle against anthrax and Contagious Bovine Pleuropneumonia (CBPP). The Commissioner for Agriculture and Rural Development, Mr. Olasunkanmi Olaleye, disclosed that 95,948 cattle have been
COVID-19
Children with demyelinating diseases, such as multiple sclerosis, anti-myelin oligodendrocyte glycoprotein associated disease, and neuromyelitis optica spectrum disorder, are at a higher risk of severe COVID-19 infection. A new study published in Pediatric Neurology has found that COVID-19 vaccination does not increase the risk of neuroinflammatory events in children with
Mpox
The resurgence of the monkeypox virus (MPXV) in non-endemic countries has raised concerns about its potential to become a global health threat. Research published in Frontiers in Public Health highlights the complexities of MPXV's epidemiology, clinical features, and transmission mechanisms. The study points to waning Orthopoxvirus immunity, inequitable
Diseases
A comprehensive vaccination campaign has been launched in Multan district at the instructions of the Punjab government, aimed at preventing deadly diseases, including measles, in the region. Deputy Commissioner Waseem Hamid Sindhu inaugurated the campaign, which includes a mass awareness rally and the administration of vitamin drops to children. The
COVID-19
Recent research highlights the vital role of COVID-19 vaccination in preventing long-term kidney damage in hospitalized patients. Studies have shown that those who received at least two doses of the Pfizer or Moderna vaccines or a single dose of the Johnson & Johnson vaccine were less likely to require dialysis
Vaccination
Vaccination rates in England have fallen to their lowest level in a decade, with many parts of the country, particularly in London, experiencing low vaccination rates. The under-fives are not receiving the necessary protection from infectious diseases, with 2,911 cases of measles recorded in England last year, the highest
COVID-19
According to a recent study published in the journal Ginekologia Polska, despite robust scientific evidence supporting the safety and efficacy of vaccinations, trust in immunizations among pregnant women has been declining. The study aimed to present women's attitudes towards vaccinations against pertussis, influenza, and COVID-19 during pregnancy, their
COVID-19
In an effort to prevent complications from COVID-19, 30 prominent professional health organizations, including the American College of Obstetricians and Gynecologists (ACOG), have signed an open letter to insurers urging them to continue covering vaccinations during pregnancy. The letter, released this week, emphasizes the safety and efficacy of COVID-19 vaccinations
COVID-19
Researchers at Boston University have published a study examining the effectiveness of COVID-19 vaccinations in individuals with a history of SARS-CoV-2 infection. The study aimed to clarify the durability of anti-viral antibody responses, which is crucial for epidemiological applications. The investigators utilized the BU ELISA protocol to measure circulating SARS-CoV-2
COVID-19
A new study analyzing data from the EudraVigilance database has shed light on the safety profile of COVID-19 vaccines. Conducted by researchers from the Medical University of Gdansk, the retrospective observational study examined 250,966 suspected serious adverse reactions (SADRs) following the administration of 733,837,251 vaccine doses against
COVID-19
Systematic reviews and individual patient data meta-analysis have shown that COVID-19 convalescent plasma (CCP) treatment is effective in increasing 60-day survival rates in B-cell depleted patients. The study, conducted on a cohort of 570 patients, found that 86.5% of patients survived for 60 days, with 70.1% achieving SARS-CoV-2
Vaccination
The Department of Health (DOH) has experienced a significant delay in vaccine procurement, with no contracts awarded six months after the start of the procurement process in January 2024. This delay has raised concerns about the country's ability to meet its ambitious health care goals, particularly in achieving
